We are pround to include news from our technologies, startups, licensees as well as funding opportunies. To this page we have collected news from our inventions and startups.
|27.3.2018||Cerenion got 220,00 € funding from European Regional Developmental Fund|
The research-based startup, Cerenion Oy, got a half million euros seed investment from Butterfly Ventures and Icebreaker.vc. It develops C-TrendTM brain monitoring technology for use in intensive care. Technology is based on standard EEG-measurement, advanced machine learning algorithms and artificial intelligence.
|16.1.2018||IndoorAtlas receives investment from Digital Ventures|
|3.1.2018||Valossa Labs: Announcement of partnership for offering rich metadata solutions for media industry|
|3.1.2018||Polar Bear Pitching - the coolest startup event with the warmest spirit 6th and 7th February 2018|
|28.12.2018||SFTec: The most interesting companies in the circular economy in Finland by Sitra|
The research-based startup, Chain Antimicrobials Oy, got an investment from Butterfly Ventures. It develops antimicrobial-coated medical devices in order to prevent formation of healthcare-associated infections.
The outcome of MoreSport-TUTLI-project of University of Oulu
Hailing from the University of Oulu, KNL Networks aims to become a leading communications service provider for the maritime industry. The company came up with the idea of harnessing high-frequency radio waves for long-distance digital communications. The HF data network offers a safer and more affordable alternative to satellite communications.
|1.11.2017||KNL Networks got a new chairman of the board|
|26.10.2017||Cerenion and Oulu University Hospital sign a framework agreement for continues clinical studies|
|18.10.2017||Cerenion receives Tekes funding for a business development project|
|1.10.2017||KNL Networks: Finnish know-how & arctic situational awareness|
|6.9.2017||Valossa got $2 million investment round from leading European media investors|
|5.9.2017||KNL Networks: Substituting traditional satelllite communications with the latest cognitive radio technology on board Klaveness vessels|
|1.9.2017||Sensmet wins entry to Nestholma Startup Program|
|22.8.2017||IndoorAtlas got investment from Yahoo! Japan|
|1.6.2017||Research based SFTec won the competition aiming to create new working places|
The innovation competition, organised for the first time for students of biochemistry and molecular medicine, culminated in a double victory. The jury was charmed by an invention reducing microbes in a refrigerator and a tea drink with protein content.
|10.4.2017||TimeGate receives funding from the European Union Structural Funds|
SURCAST-project aims to develop online-monitoring systems and numerical models for defects identification in the steel casting process.
IndoorAtlas, startup of University of Oulu, the global leader in indoor positioning partners with Spottio, a pioneer in digitization of retail stores.
|14.2.2017||SfTec made collaboraton agreements with Global EcoSolutions Oy and DustComb Oy|
|26.1.2017||Luxmet in top 25 in Nordic Cleantech Open|
Paras Biopharmaceuticals has received the ESQR’s Quality Choice Prize 2016 from the European Society for Quality Research (ESQR) for their hard work and achievements, in the presence of the international business community for its commitment to quality, excellence and continuous improvement.
|27.10.2017||KNL Networks raises $10 million|
|KNL Newtworks, a startup company of University of Oulu, developes a new wireless communications system which works also at most extreme and isolated locations in Earth.|
Paras Biopharmaceuticals got a multi-million international investment
Paras Biopharmaceuticals Finland Oy, a startup company of University of Oulu, has developed technology for the production of an osteoporosis drug which will result into a very economical production of the medicine.
It has recently secured necessary investment from a UK based ASAP Growth Ltd who has extensive entrepreneurial experience in pharmaceuticals. This multi-million-euro investment is a key enabler in bringing further development of the product and the potential expansion of activities in Oulu.
The technologies of Paras Biopharmaceuticals are partly based on the research made at research group of Prof. Lloyd Ruddock at the Faculty of Biochemistry and Molecular Medicine.